Authors



Jeegisha T. Patel, PharmD

Latest:

Prevention of Shingles: The Zostavax Vaccine

Dr. Patel is a clinical assistant professor in the Department of Pharmacy Practice, Oregon State University/ Oregon Health & Science University, College of Pharmacy, Portland campus.


Heather A. Brand, PharmD, MSPBA Candidate

Latest:

The Importance of Outcomes in High Cost Drug Therapies

Pharmaceutical manufacturers historicially reaped the benefits of operating independently in pricing and discounting drugs based on volume sold in the United States.


Mike Popovich

Latest:

Exploring the History and Rise of Data Opportunity Systems

The opportunity to leverage patient immunization history and data at the point of care in a pharmacy environment can increase the trust and credibility of the pharmacist as a member of the patient’s health care team.


Sandra Leal, PharmD, MPH

Latest:

Quality Initiatives: Pharmacists in the Forefront

Pharmacists can lead quality transformation within their organizations.


Geeta Maggo, PharmD

Latest:

Renin Antagonists: An Alternative to Controlling Hypertension

Identification of aliskiren's role in the management of hypertension has been the focus of several clinical trials which have demonstrated its effectiveness in blood pressure reduction with few side effects.


Christopher Daly, PharmD, MBA, BCACP

Latest:

Not Just Dispensing: The Unique Role of Pharmacists in an Outpatient Research Pharmacy

Pharmacists can serve as essential members of a research team in a role that involves much more than traditional dispensing functions.



Amy M. Lugo, PharmD, BCPS, BC-ADM

Latest:

The Role of PARP Inhibitors in Treating Ovarian Cancer

Rucaparib is FDA approved in patients with a BRCA mutation and who have received 2 more prior lines of previous chemotherapy.



Jan Berger, MD, MJ

Latest:

The Opportunities and Challenges of Specialty Distribution

The distribution of infusible specialty medications comes with difficulties that must be addressed by pharmacies and payers.


Taylor Jones, PharmD, BCPS

Latest:

Influenza Vaccinations During the COVID-19 Pandemic

Given the collision of COVID-19 and flu season, receiving the flu vaccine may hold additional benefits by reducing symptoms that may be confused with those of the novel coronavirus.


Lisa Katzki, RN, BSN, PHN

Latest:

Emergency Preparedness: When Disaster Strikes

For patients who require life-sustaining medications, emergency preparedness is essential. Here is a game plan to guide you and your patients when facing the unexpected.



Jose Alvir, DrPH

Latest:

Impact of Co-Payment Discounts on Antidepressant Medication Adherence and Costs

A unique co-payment discount program for antidepressants was associated with higher antidepressant medication adherence, lower likelihood of discontinuation, and lower healthcare costs.


Adeola O. Grillo, PhD

Latest:

Optimization of Biopharmaceuticals

Pharmacists should be knowledgeable about the different approaches used to modify biopharmaceuticals and how they affect stability, dosing, safety, and efficacy.




Jerry A. Barbee Jr, PharmD, CPh

Latest:

CAR-NK Cell Immunotherapy Demonstrates Potential for Treating Patients With Relapsed or Refractory Lymphomas

Patients with relapsed/refractory leukemia and lymphomas generally have a grim prognosis, which has paved the way for immunotherapy treatments.


Michelle Sriprasert, MPH

Latest:

US Cost-Effectiveness of Saxagliptin in Type 2 Diabetes Mellitus

Saxagliptin, in combination with metformin, provides a durable, well-tolerated, and cost-effective treatment option for patients with type 2 diabetes mellitus, from a US payer perspective.


Joseph Barone, PharmD, BCOP

Latest:

Oncology Pharmacy Education Network: Finding Solutions Together

The Association of Community Cancer Centers (ACCC) Oncology Pharmacy Education Network (OPEN) provides resources that are pharmacist driven and developed.


Amy Lee, PharmD Candidate

Latest:

Dolutegravir Is Susceptible to Chelation-Type Interactions

Common medications containing polyvalent cations should be separated to prevent decreased absorption of the HIV therapy.


Richard Hillestad, PhD

Latest:

Comparative Effectiveness of Fidaxomicin for Treatment of Clostridium Difficile Infection

Our analysis models the clinical and economic value of fidaxomicin for the treatment of Clostridium difficile infection compared with metronidazole and vancomycin.



Allison M. Bell, PharmD, MSc, BCPS

Latest:

Patterns of Specific Testing for Patients With Chronic Myelogenous Leukemia

Study assessed chemotherapy use in patients with chronic myelogenous leukemia (CML) to determine how use of CML-specific tests impacted drug selection and modification.


Christopher S. Shain, PharmD, BCPS, Assistant Vice President, McKesson 340B Solutions

Latest:

Understanding and Navigating Specialty and Orphan Drug Challenges in the 340B Program

Failure to recognize the interests of manufacturers to ensure proper use of 340B pricing may result in 340B hospitals missing the opportunity to secure and retain discounts on key orphan and specialty drugs or may render them unable to access the drugs at all.


Lina Asmar, PhD

Latest:

Cost-Effectiveness of Docetaxel-Cyclophosphamide Versus Doxorubicin-Cyclophosphamide for Breast Cancer

Compared with doxorubicin plus cyclophosphamide, docetaxel plus cyclophosphamide was highly cost-effective for adjuvant treatment of operable breast cancer.



Jessica Langley

Latest:

Pharmacy Technicians to Play a Key Role in Upcoming Flu Season

On August 4, 2021, the Biden administration expanded the authority of pharmacy technicians under the PREP Act to allow pharmacy technicians to administer adult flu vaccines during the 2021-2022 flu season.


Jessica M. Ogburn, PharmD Candidate

Latest:

CANDOR Creates a Safer Health Care System

Now in 4 states, the program allows providers to admit errors without worry about legal ramifications in the courtroom.